Clinical Trial Update: Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating toripalimab in combination with chemotherapy and bevacizumab as first-line treatment for advanced cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN